Let's call the meeting to order.
I want to start by thanking our panellists for attending and coming forward on the important issue of pharmaceuticals.
We look forward to your presentations to the committee, as the committee decides whether, perhaps in the fall, we want to look at this as a larger study to see if there is something we can do that would be productive for the committee's time.
I want to again thank you all for coming. We'll start in the order that I have.
For the committee's information, we will start with an hour and a half. We'll have the questioning, as well as the presentation time. We'll then go into an in camera session on the report of the committee on fetal alcohol spectrum disorder. There is also one motion before the committee that we'll be dealing with during the public time and perhaps an appointment position that we'll deal with at the same time. That's for the committee's information.
We'll now move on to our witnesses, and we will start.
We have Mr. Brett Skinner from the Fraser Institute, Ken Fraser from the Fraser Group, Barbara Mintzes from the University of British Columbia, and Ingrid Sketris from Dalhousie University.
Thank you again for coming.
We'll start with Mr. Skinner. You have 10 minutes.